Index of Authors

A list of all persons who contribute to the sessions of this conference. Please select a letter below to list all persons with the corresponding surname. Select the presentation in the right-hand column to access session and presentation details.

 
List by Initial Letter: A  B  C  D  E  F  G  H  I  J  K  L   M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  Å  Ø  Č  Š 
List Options: Authors and Sessions · Authors and Presentations   |   Include Session Chairs
 
Author(s) Organization(s) Session
M Turnbull, DougWellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United KingdomTea Break and poster session
Ma, CharisCenter for Mitochondrial and Epigenomic Medicine, The Children’s Hospital of PhiladelphiaPoster session
Ma, HongCenter for Embryonic Cell and Gene Therapy, Oregon Health and Science University, United States of AmericaSession 4.3: Therapy 3: reproductive options and mtDNA editing
Tea Break and poster session
Maack, ChristophDepartment of Translational Research, Comprehensive Heart Failure Center (CHFC), Medical Clinic 1, University ClinicWürzburg,Würzburg, GermanyTea Break and poster session
Maas, FransRadboudUMC, Translational Metabolic Laboratory, Dept of Pediatrics, Nijmegen, The NetherlandsTea Break and poster session
Macaluso, AgneseIRCCS - Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica - Bologna (Italy)Session 2.2: Clinical 1: from new genes to old and novel phenotypes
Tea Break and poster session  Presenter
Macao, BertilUniversity of Gothenburg, SwedenTea Break and poster session  Presenter
Macao, BertilDepartment of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, SE 405 30 Gothenburg, SwedenTea Break and poster session
Tea Break and poster session
Mach, RobertUniversity of Pennsylvania, United States of AmericaTea Break and poster session
Macken, William LDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK;
NHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London, UK
Session 2.2: Clinical 1: from new genes to old and novel phenotypes  Presenter
Macken, William L.Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK;
NHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London, UK
Session 2.2: Clinical 1: from new genes to old and novel phenotypes
Tea Break and poster session  Presenter
Mackenzie, SarahThe Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UKSession 2.1: mtDNA maintenance and expression
Tea Break and poster session
MacMullen, Laura EMitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, USAPoster session
MacShane, MandiPerth Children’s Hospital, Perth, AustraliaTea Break and poster session
Madhuri, VissapragadaJawaharlal Nehru Centre for Advanced Scientific Research, IndiaTea Break and poster session
Madia, FrancescaIRCCS Istituto Giannina Gaslini, GenoaTea Break and poster session
Madji Hounoum, BlandineUniversité Côte d’Azur, Inserm U1065, C3M, Nice, FranceTea Break and poster session
Madruga, MarcosNeuropediatra, Neurolinkia & Hospital Viamed Santa Ángela De la Cruz, Sevilla, SpainSession 4.1: Therapy 1: preclinical developments
Maeda, RyotaroKyoto prefectural University of Medicine, JapanTea Break and poster session
Maeki, MasatoshiFaculty of Engineering, Hokkaido University, JapanTea Break and poster session
Maggio, MaurizioFondazione IRCCS Cà Granda Ospedale Policlinico, ItalyPoster session
Session 1.1: The impact of mtDNA variation and environment on rare and common diseases
Maggioni, MarcoFondazione IRCCS Cà Granda Ospedale Policlinico, ItalyPoster session
Session 1.1: The impact of mtDNA variation and environment on rare and common diseases
Magnifico, Maria ChiaraDepartment of Biosciences Biotechnologies and Environment, University of Bari, ItalyPoster session
Magnoni, PenelopeIRCCS, Istituto delle Scienze Neurologiche di Bologna, Italy - Programma di NeurogeneticaTea Break and poster session  Presenter
Magnowska, MartaCentre of New Technologies, University of Warsaw, PolandPoster session
Magri, FrancescaIRCCS Cà Granda Ospedale Maggiore Policlinico Milan, ItalyTea Break and poster session
Tea Break and poster session
Mahdi, Mahdi SIMol Polish Academy of Sciences, Poland;
ReMedy International Research Agenda
Tea Break and poster session
Maheshwor, ThapaShuzhao Li Lab The Jackson Laboratory for Genomic Medicine, Farmington, USATea Break and poster session
Maioli, Maria AntoniettaCentro Sclerosi Multipla, P.O. Binaghi, ASL Cagliari, ItalySession 2.2: Clinical 1: from new genes to old and novel phenotypes
Tea Break and poster session
Maiti, PriyankaUniversity of Miami, United States of AmericaTea Break and poster session
Majamaa, KariNeurocenter, Oulu University Hospital, Oulu, Finland;
Research Unit of Clinical Medicine, Medical Research Center, University of Oulu and Oulu University Hospital, Oulu Finland
Poster session
Session 3.4: Clinical 2: natural history, biomarkers and outcome measures
Majamaa, KariUniversity of Oulu and Oulu University Hospital, FinlandTea Break and poster session
Makrecka-Kuka, MarinaLab Pharmaceut Pharmacol, Latvian Inst Organic Synthesis, Riga, LatviaPoster session
Malagelada, CarolinaUniversity Hospital Vall d'Hebron. Barcelona. SpainTea Break and poster session
Malerba, GiovanniDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, ItalySession 5.1: Late breaking news session
Malhotra, RheaBroad Institute of MIT and Harvard, Cambridge, MA 02142, USASession 2.4: New technological developments and OMICS
Malik, Afshan NKing's College, London, UKPoster session
Session 3.2: Mitochondrial mechanisms in neurodegeneration and neurodevelopment
Malitsky, SergeyLife Sciences Core Facilities, Weizmann Institute of Science, IsraelSession 5.1: Late breaking news session
Tea Break and poster session
Malko-Baverel, VassilissaUniversité Paris Cité, NeuroDiderot, Inserm, F-75019 Paris, FrancePoster session
Tea Break and poster session
Malpeli, GiorgioDepartment of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, Verona, ItalySession 5.1: Late breaking news session
Manara, PaolaUniversity of Miami, United States of AmericaTea Break and poster session
Mancini, RitaDepartment of Clinical and Molecular Medicine, University of Rome La Sapienza, 00198 Rome, ItalyTea Break and poster session
Mancuso, M.Department of Clinical and Experimental Medicine, Neurological Institute, University of Pisa & AOUP, ItalyTea Break and poster session
Mancuso, MichelangeloNeurological Institute of Pisa, ItalyPoster session
Mancuso, MichelangeloUniversity of Pisa, ItalySession 3.4: Clinical 2: natural history, biomarkers and outcome measures
Mancuso, MichelangeloNeurological Institute, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalySession 4.2: Therapy 2: clinical trials
Mancuso, MichelangeloDepartment of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, ItalyTea Break and poster session  Presenter
Tea Break and poster session
Tea Break and poster session
Tea Break and poster session
Mancuso, MichelangeloNeurological Institute, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyTea Break and poster session
Manero, FlorenceUniversity of Angers, SFR ICAT, SCIAM, 49000 Angers, FrancePoster session
Manfredi, GiovanniWeill Cornell Medicine, Brain and Mind Research Institute, New York, NYPoster session
Manfredi, GiovanniFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USAPoster session
Manfredi, GiovanniWeill Cornell Medicine, Brain and Mind Research Institute, New York, NYSession 2.3: Modelling pathogenic mechanisms: OXPHOS, metabolic rewiring and tissue specificity
Manfredi, GiovanniWeill Cornell Medicine, United States of AmericaSession 3.3: Metabolic stress responses in mitochondrial diseases and cancer
Manfredi, GiovanniFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, 407 East 61st Street, New York, NY 10065, USA.Tea Break and poster session
Manfredi, GiovanniWeill Cornell Medicine, United States of AmericaTea Break and poster session
Mangili, GiovannaASST Papa Giovanni XXIII, Bergamo, ItalyTea Break and poster session
Maniaci, MariannaDepartment of Experimental Oncology, European Institute of Oncology (IEO), IRCCS Milano, ItalyTea Break and poster session
Manjithaya, RaviJawaharlal Nehru Centre for Advanced Scientific Research, IndiaTea Break and poster session
Mann, MatthiasMax-Planck Institute of Biochemistry, GermanySession 3.3: Metabolic stress responses in mitochondrial diseases and cancer
Tea Break and poster session
Manners, David NeilDepartment of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, ItalyTea Break and poster session  Presenter
Manners, David NeilIRCCS Instituto delle Scienze Neurologiche di Bologna, Bologna, Italy;
Department of Life Quality Studies, University of Bologna
Tea Break and poster session  Presenter
Manolaras, IoannisInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM U1258, CNRS UMR7104, Université de Strasbourg, FrancePoster session
Manzoli, LuciaDepartment of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, Bologna, ItalyTea Break and poster session
Manzoni, E.Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna;
IRCCS Istituto delle Scienze Neurologiche, Neuropsichiatria dell’età pediatrica, Bologna
Tea Break and poster session  Presenter
Manzoni, FrancescaBolzano Hospital, ItalyPoster session  Presenter
Marcello, ElenaDepartment of Pharmacological and Biomolecular Sciences -DiSFeB, Università degli Studi di Milano, Milan, ItalyTea Break and poster session
Marchet, SilviaFondazione IRCCS Istituto Neurologico Carlo Besta, Department of Experimental Neuroscience, Unit of Medical Genetics and Neurogenetics, Milan, ItalySession 4.2: Therapy 2: clinical trials  Presenter
Marchet, SilviaUnit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo BestaTea Break and poster session
Marchet, SilviaFondazione IRCCS Istituto Neurologico Carlo Besta, Department of Experimental Neuroscience, Unit of Medical Genetics and Neurogenetics, Milan, ItalyTea Break and poster session  Presenter
Marchi, MarcoClinical Genetics Unit, Department of Women’s and Children’s Health, University of Padua, and Istituto di Ricerca Pediatrica (IRP) Città della Speranza, Padua, ItalyPoster session  Presenter
Marco-Brualla, JoaquínUniversity of Zaragoza, Peaches Biotech Group, SpainPoster session
Marco-Brualla, JoaquínDepartment of Biochemistry and Molecualr and Cellular Biology, Universidad de Zaragoza, Spain;
Peaches Biotech Group, Madrid, Spain
Tea Break and poster session
Marelsson, Sigurður E.Lund University, Sweden;
Children's Medical Center, Landspitali-The National University Hospital of Iceland, Reykjavík, Iceland
Tea Break and poster session
Maresca, AlessandraIRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, Bologna, ItalyPoster session
Poster session
Poster session
Poster session
Session 2.2: Clinical 1: from new genes to old and novel phenotypes
Session 3.1: Inflammation and Immunity as mitochondrial contributor to pathology  Presenter
Session 4.1: Therapy 1: preclinical developments
Tea Break and poster session
Maresca, AlessandraIRCCS Institute of Neurological Sciences of Bologna, ItalyTea Break and poster session
Maresca, AlessandraIRCCS Istituto delle Scienze Neurologiche di Bologna, ItalyTea Break and poster session
Tea Break and poster session
Maresca, AlessandraIRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, Bologna, ItalyTea Break and poster session
Tea Break and poster session
Tea Break and poster session
Tea Break and poster session
Margari, NikiEndocrinology Department, University College London Hospital, London, UKTea Break and poster session
Mariagrazia, VolpeTelethon Institute of Genetics and Medicine,ItalyTea Break and poster session
Mariotti, CaterinaUnita` di Genetica delle Malattie Neurodegenerative e Metaboliche, Fondazione IRCCS Istituto Neurologico "Carlo Besta", Milan, 20126, ItalyPoster session
Mariotti, CaterinaUnit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo BestaTea Break and poster session
Marković, AleksandraInstitute of Physiology of the Czech Acad. Sci., Prague, Czech RepublicPoster session  Presenter
Marmyleva, AnastasiiaUniversity of Helsinki, FinlandTea Break and poster session  Presenter
Maroofian, RezaDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UKSession 2.2: Clinical 1: from new genes to old and novel phenotypes
Tea Break and poster session
Marsh, EricChildren's Hospital of Philadelphia, United States of AmericaTea Break and poster session
Marshall, Aidan ScottImperial College London, United KingdomTea Break and poster session  Presenter
Martí, ItxasoPediatric Neurology Department, Donostia University Hospital, San Sebastian, SpainSession 4.1: Therapy 1: preclinical developments
Martí, María JoséLaboratory of Parkinson Disease and Other Neurodegenerative Movement Disorders, IDIBAPS-Hospital Clínic de Barcelona, Institut de Neurociències, UB, 08036 Barcelona, Spain and Centre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED CB06/05/0018), 28029 Madrid, Spain.Poster session
Martí, RamonResearch Group on Neuromuscular and Mitochondrial Disorders, Vall d’Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain;
Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
Poster session
Marti, RamonBiomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Barcelona;
Vall d’Hebron Research Institute, Autonomous University of Barcelona, Barcelona, Spain.
Session 2.2: Clinical 1: from new genes to old and novel phenotypes
Martí, RamonVall d'Hebron Research Institute, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Autonomous University of Barcelona, Barcelona, SpainSession 2.2: Clinical 1: from new genes to old and novel phenotypes
Martí, RamonResearch Group on Neuromuscular and Mitochondrial Diseases, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, Spain;
Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
Session 4.1: Therapy 1: preclinical developments
Martí, RamonVall d’Hebron Institut de Recerca, Barcelona, SpainSession 4.2: Therapy 2: clinical trials
Martí, RamonSpanish Network for Biomedical Research in Rare Diseases (CIBERER);
Research Group on Neuromuscular and Mitochondrial Diseases, Vall d’Hebron Research Institute, Autonomous University of Barcelona, Barcelona
Tea Break and poster session
Martí, RamonVall d'Hebron Research Institute, Centro de Investigación Biomédica en Red de Enfermedades Raras-CIBERER, Autonomous University of Barcelona, Barcelona, SpainTea Break and poster session
Martí, RamonResearch Group on Neuromuscular and Mitochondrial Diseases, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona - Barcelona (Spain);
Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III - Madrid (Spain)
Tea Break and poster session
Marti, RamonVall d’Hebron Research Institute, Universitat Autònoma de Barcelona, and Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Barcelona, Catalonia;
Vall d’Hebron Research Institute, Autonomous University of Barcelona, Barcelona, Spain.
Tea Break and poster session
Tea Break and poster session
Martí, RamonVall d'Hebron Research Institute, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Autonomous University of Barcelona, Barcelona, SpainTea Break and poster session
Marti Gutierrez, NuriaCenter for Embryonic Cell and Gene Therapy, Oregon Health and Science University, United States of AmericaSession 4.3: Therapy 3: reproductive options and mtDNA editing  Presenter
Session 4.3: Therapy 3: reproductive options and mtDNA editing
Tea Break and poster session
Martikainen, Dr. RiikkaUniversity of Eastern Finland, FinlandPoster session
Martikainen, Mika HenrikUniversity of Oulu and Oulu University Hospital, FinlandTea Break and poster session  Presenter
Martin, Colin T.Department of Chemistry and Center for Nucleic Acids Science and Technology, Carnegie Mellon University, Pittsburgh, Pennsylvania, USAPoster session
Martin, EllenoreSydney Children’s Hospitals Network, Westmead, AustraliaTea Break and poster session
Martín, Miguel AMitochondrial and Neuromuscular Diseases Laboratory, Instituto de Investigación Sanitaria Hospital ‘12 de Octubre’ (‘imas12’), Madrid, Spain;
Spanish Network for Biomedical Research in Rare Diseases (CIBERER), U723, Spain.;
Servicio de Genética. Hospital Universitario ‘12 de Octubre’. Madrid, Spain
Poster session
Tea Break and poster session
Martín, Miguel A.Mitochondrial Diseases Laboratory, Research Institute, Universitary Hospital 12 de Octubre (Imas12), 28041 Madrid, Spain.;
Centre for Biomedical Network Research on Rare Diseases (CIBERER), Spain.
Poster session
Martín, Miguel A.Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain;
Mitochondrial and Neuromuscular Disorders Group, '12 de Octubre’ Hospital Research Institute (imas12), Madrid, Spain
Session 4.1: Therapy 1: preclinical developments
Martin, Miguel A.Hospital Universitario 12 de Octubre, imas12 Research Institute, Madrid, Spain;
Spanish Network for Biomedical Research in Rare Diseases (CIBERER)
Tea Break and poster session
Martín, Miguel ÁngelCIBERER—Spanish Biomedical Research Centre in Rare Diseases; Madrid, Spain.;
Grupo de Enfermedades Mitocondriales, Instituto de Investigación Hospital 12 de Octubre (imas12). Madrid. Spain.
Poster session
Martín Hernández, ElenaMitochondrial and Neuromuscular Diseases Laboratory, Instituto de Investigación Sanitaria Hospital ‘12 de Octubre’ (‘imas12’), Madrid, Spain;
Spanish Network for Biomedical Research in Rare Diseases (CIBERER), U723, Spain;
Unidad Pediátrica de Enfermedades Raras, Hospital Universitario ‘12 de Octubre’, Madrid, Spain.;
Centro Nacional de Referencia para Errores Congénitos del Metabolismo (CSUR) y Centro Europeo de Referencia para Enfermedades Metabólica Hereditarias (MetabERN), Madrid, Spain
Tea Break and poster session
Martín Hernández, ElenaUnidad Pediátrica de Enfermedades Raras, Enfermedades Mitocondriales y Metabólicas Hereditarias, Hospital 12 de Octubre, E-28041, Madrid, Spain.;
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), U723, E-28041 Madrid, Spain.
Tea Break and poster session
Martín Mur, BeatrizCNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, SpainPoster session
Martin-Negrier, Marie-LaureUnité fonctionnelle d’histologie moléculaire, Service de pathologie, CHU Bordeaux-GU Pellegrin, BordeauxTea Break and poster session
Martinek, VaclavDepartment of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic.Poster session
Martinell, MarcMinoryx Therapeutics SL, Barcelona, SpainTea Break and poster session
Martinelli, D.Division of Metabolism, Bambino Gesù Children's Hospital IRCCS, Rome, ItalyTea Break and poster session
Martinelli, DiegoDivision of Metabolism, Bambino Gesù Children’s Hospital, IRCCS, Rome, ItalySession 3.1: Inflammation and Immunity as mitochondrial contributor to pathology
Martinelli, DiegoMetabolism Division, Children Hospital Bambino Gesù, RomeTea Break and poster session
Martinelli, DiegoBambino Gesù Children Hospital, ItalyTea Break and poster session
Martinelli, DiegoDivision of Metabolism, Department of Pediatric Subspecialties, Bambino Gesù Children's Hospital, Rome, ItalyTea Break and poster session
Martinelli, DiegoDivision of Metabolism, Bambino Gesù Children’s Hospital, IRCCS, Rome, ItalyTea Break and poster session
Martínez, AntonioInstituto de Investigación Sanitaria La PrincesaTea Break and poster session
Martínez Azorín, FranciscoLaboratorio de Enfermedades Mitocondriales. Instituto de Investigación Hospital 12 de Octubre (i+12), E-28041 Madrid, Spain.;
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), U723, E-28041 Madrid, Spain.
Tea Break and poster session
Martinez Ruiz, LauraInstitute of Biotechnology, Biomedical Research Center, Health Sciences Technology Park, University of Granada, Granada, Spain;
Department of Physiology, Faculty of Medicine, University of Granada, Granada, Spain;
Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Investigación Biosanitaria (Ibs), Granada, San Cecilio University Hospital, Granada, Spain
Tea Break and poster session  Presenter
Martínez Ruíz, LauraInstitute of Biotechnology;
Biomedical Research Centre;
University of Granada, Spain
Tea Break and poster session
Martínez-Gálvez, Juan M.Physiology Department, Biomedical Research Center, University of Granada, Granada, Spain;
Biofisika Institute (CSIC, UPV-EHU) and Department of Biochemistry and Molecular Biology, University of Basque Country, Leioa, Spain;
Ibs.Granada, Granada, Spain
Poster session  Presenter
Poster session
Tea Break and poster session
Maschmeyer, PatrickBerlin Institute of Health at Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany;
Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), 10115 Berlin, Germany
Session 2.4: New technological developments and OMICS
Masgrau, RoserUniversitat Autònoma de Barcelona, Institut de Neurociències, Bellaterra, SpainTea Break and poster session
Mason, ShayneNorth-West University, South AfricaTea Break and poster session
Massarella, ClareWellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute; NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle upon Tyne NE2 4HH, UKTea Break and poster session
Masud, Ali Julfiker MdFaculty of Biochemistry and Molecular Medicine, University of Oulu, FinlandTea Break and poster session  Presenter
Mathisen, LindaDepartment of Medical Genetics, Oslo University Hospital, NorwayTea Break and poster session
Tea Break and poster session  Presenter
Matondo, MarietteInstitut Pasteur, Bioinformatics and Biostatistics Hub, Université Paris Cité, Paris, France.Poster session
Matondo, MarietteInstitut Pasteur, Proteomics Core Facility, MSBio UtechS, UAR CNRS 2024, Université Paris Cité, Paris, FranceTea Break and poster session
Mattiaccio, AlessandroDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, BO, ItalyTea Break and poster session
Mauri, AlessandraInstitute for Research on Cancer and Aging, Nice (IRCAN) - FrancePoster session
Mauri-Crouzet, AlessandraUniversité Côte d’Azur, Inserm U1081, CNRS UMR7284, IRCAN, CHU de Nice, Nice (France)Poster session
Mauri-Crouzet, AlessandraIRCAN, UMR 7284/INSERM U1081/UCA, Nice, FranceTea Break and poster session
Mauthe, MarioMolecular Cell Biology Section, Department of Biomedical Sciences of Cells & Systems, University of Groningen, University Medical Center Groningen, 9713 AV Groningen, The Netherlands;
Expertise Center Movement Disorders Groningen, University Medical Center Groningen, 9713 AV Groningen, The Netherlands
Session 5.1: Late breaking news session
Tea Break and poster session
Mavraki, EleniNHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;
Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK
Tea Break and poster session
Mayer, FionaMax Planck Institute for Biology of Ageing, Cologne, GermanyTea Break and poster session
Mayr, J.University Children's Hospital, Paracelsus Medical University (PMU), 5020 Salzburg, AustriaTea Break and poster session
Mayr, Johannes A.University Children's Hospital, Paracelsus Medical University, Salzburg, AustriaSession 2.2: Clinical 1: from new genes to old and novel phenotypes
Mazunin, IlyaSkolkovo Institute of Science and Technology, Moscow, RussiaSession 4.3: Therapy 3: reproductive options and mtDNA editing
Tea Break and poster session
Mazza, TommasoLaboratory of Bioinformatics, Fondazione IRCCS Casa Sollievo della Sofferenza, Rome, ItalyPoster session
McAvoy, KevinFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USAPoster session  Presenter
McBride, HeidiMcGill University, CanadaTea Break and poster session
McCormick, ElizabethChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania, USAPoster session
McCormick, Elizabeth MMitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, USAPoster session
McCormick, Elizabeth M.Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PATea Break and poster session
McFarland, RobertWellcome Centre for Mitochondrial Research and Institute for Translational and Clinical Research, ewcastle University, United KingdomPoster session
McFarland, RobertWellcome Centre for Mitochondrial Research, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK;
Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK;
NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK;
National Institute for Health and Care Research (NIHR) Newcastle Biomedical Research Centre (BRC), Newcastle University and The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;
Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, UK
Poster session
Session 2.1: mtDNA maintenance and expression
Session 2.2: Clinical 1: from new genes to old and novel phenotypes
Session 3.4: Clinical 2: natural history, biomarkers and outcome measures
McFarland, RobertWellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute; NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle upon Tyne NE2 4HH, UK;
Department of Neurosciences, NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle upon Tyne NE2 4HH, UK;
NHS Highly Specialised Rare Mitochondrial Disorders Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE2 4HH
Tea Break and poster session
Tea Break and poster session
McFarland, RobertWellcome Centre for Mitochondrial Research, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne;
Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne
Tea Break and poster session
McFarland, RobertWellcome Centre for Mitochondrial Research and Institute for Translational and Clinical Research, Newcastle University, Newcastle upon Tyne, UKTea Break and poster session
McFarland, RobertWellcome Centre for Mitochondrial Research. Clinical and Translational Research Institute. Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, United Kingdom;
NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children, Newcastle upon Tyne Hospitals NHS Foundation Trust
Tea Break and poster session
McFarland, RobertWellcome Centre for Mitochondrial Research, Faculty of Medical Sciences, Newcastle University, UKTea Break and poster session
McFarland, RobertWellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, UK;
NHS Highly Specialised Service for Rare Mitochondrial Disorders, The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK
Tea Break and poster session
McFarland, RobertWellcome Centre for Mitochondrial Research, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United KingdomTea Break and poster session
McFarland, RobertNational Institute for Health and Care Research (NIHR) Newcastle Biomedical Research Centre (BRC), Newcastle University and The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;
Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, UK;
NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Tea Break and poster session
McGill, JimQueensland Children’s Hospital, Brisbane, AustraliaTea Break and poster session
McKittrick, CarolineDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UKSession 2.2: Clinical 1: from new genes to old and novel phenotypes
McKnight, Cameron L.Murdoch Children’s Research Institute, The Royal Children's Hospital, Melbourne, VIC, Australia;
Department of Paediatrics, The University of Melbourne, Melbourne, VIC, Australia
Poster session
McManus, MeaganUniversity of Pennsylvania, United States of AmericaPoster session
McManus, Meagan JoyChildren's Hospital of Philadelphia, United States of AmericaTea Break and poster session  Presenter
McWilliams, ThomasSTEMM, Faculty of Medicine, University of Helsinki, 00290 Helsinki, FinlandPoster session
McWilliams, Thomas G.STEMM Research Program, Biomedicum Helsinki, Faculty of Medicine, University of Helsinki, Helsinki, FinlandPoster session
Meade, PatriciaDepartment of Biochemistry and Molecualr and Cellular Biology, Universidad de Zaragoza, Spain;
Institute for Biocomputation and Physics of Complex Systems (BIFI), Zaragoza, Spain
Tea Break and poster session
Medina-Carbonero, MartaDept. Ciències Mèdiques Bàsiques, Fac. Medicina, Universitat de Lleida. IRB Lleida.Poster session
Poster session
Meij, PaulineCenter for Cell and Gene Therapy (CCG), Leiden University Medical Center, Leiden, The NetherlandsSession 4.2: Therapy 2: clinical trials
Meira, WillianInstitute for Research on Cancer and Aging, Nice (IRCAN) - FrancePoster session  Presenter
Meldau, SuritaUniversity of Cape Town, Cape Town, South Africa;
National Health Laboratory Sevices, South Africa
Tea Break and poster session
Tea Break and poster session  Presenter
Meli, AdrianaDepartment of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, Pisa, ItalyTea Break and poster session
Melià, Maria JesúsResearch Group on Neuromuscular and Mitochondrial Disorders, Vall d’Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain;
Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
Poster session
Mena, DéboraCNC-Center Neurosci and Cell Biol, Univ Coimbra, Portugal;
CIBB-Center for Innovative Biomed Biotechnol, Univ Coimbra, Portugal;
PDBEB-PhD Programme in Exp Biol Biomed, IIUC, Univ Coimbra, Portugal
Poster session
Menardy, FabienNeuroscience Institute, Autonomous University of Barcelona, Bellaterra, SpainTea Break and poster session
Mencacci, NiccolòNorthwestern University, Feinberg School of Medicine, Chicago, USATea Break and poster session
Meneri, MagiIRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy;
Dino Ferrari Center, University of Milan, Milan, Italy
Tea Break and poster session
Meneri, MegiDino Ferrari Center, University of Milan, Italy;
IRCCS Cà Granda Ospedale Maggiore Policlinico Milan, Italy
Tea Break and poster session
Menger, Katja E.Wellcome Centre for Mitochondrial Research, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK;
Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK
Session 2.1: mtDNA maintenance and expression
Tea Break and poster session
Menni, F.Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Regional Clinical Center for expanded newborn screening, Milan, ItalyTea Break and poster session
Menni, FrancescaIRCCS Cà Granda Ospedale Maggiore Policlinico Milan, ItalyTea Break and poster session
Mennuni, MaraKarolinska Institute, SwedenPoster session  Presenter
Mennuni, MaraDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, SwedenTea Break and poster session
Menon, VilasCenter for Translational & Computational Neuroimmunology, Department of Neurology and the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University Irving Medical Center, New York NY, USASession 3.2: Mitochondrial mechanisms in neurodegeneration and neurodevelopment
Menzel, RalphHumboldt-Universität zu Berlin, Berlin, GermanyTea Break and poster session
Mercolini, LauraDepartment of Pharmacy and BioTechnology, University of Bologna, ItalyPoster session
Meroni, MaricaFondazione IRCCS Cà Granda Ospedale Policlinico, ItalyPoster session
Poster session
Session 1.1: The impact of mtDNA variation and environment on rare and common diseases
Meroño Ortega, CarolinaInstituto Universitario de Biología Molecular – UAM (IUBM-UAM), Departamento de Biología Molecular, Universidad Autónoma de Madrid, 28049 Madrid, Spain;
Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas - Universidad Autónoma de Madrid (CSIC-UAM), 28049 Madrid, Spain
Tea Break and poster session  Presenter
Messahel, SouadPerot Foundation Neuroscience Transla-tional Research Center (PNTRC), The University of Texas Southwestern Medical Center O'Donnell Brain InstituteTea Break and poster session
Messias, Ana C.Institute of Structural Biology, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany;
Bavarian NMR Centre, Department of Bioscience, School of Natural Sciences, Technical University of Munich, 85747 Garching, Germany
Session 5.1: Late breaking news session
Tea Break and poster session
Meyer-Dihet, GéraldinePhysiopathology and Genetics of Neurons and Muscles Laboratory, Institut NeuroMyoGène, Lyon, FrancePoster session
Meyrick, JonathanWellcome Centre for Mitochondrial Research, United KingdomTea Break and poster session  Presenter
Michell, CraigUniversity of Eastern FinlandPoster session
Tea Break and poster session
Tea Break and poster session
Michelson, JeremyColumbia University Irving Medical Center, United States of AmericaSession 3.4: Clinical 2: natural history, biomarkers and outcome measures
Tea Break and poster session
Miciaccia, MorenaUniversity of Bari "Aldo Moro", ItalyTea Break and poster session
Migliorato, AlbaUnit of Neurology and Neuromuscular Disorders, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.Tea Break and poster session
Mignon, VirginieUniversité de Paris, UMR-S 1144 Inserm, 75006 Paris, France;
Université Paris Cité, Platform of Cellular and Molecular Imaging, US25 Inserm, UAR3612 CNRS, 75006 Paris, France
Poster session
Tea Break and poster session
Miinalainen, IlkkaElectron microscopy, Biocenter Oulu, University of Oulu, Oulu, FinlandPoster session
Mikešová, JanaInstitute of Physiology of the Czech Acad. Sci., Prague, Czech RepublicPoster session
Mikhalchenko, AlekseiCenter for Embryonic Cell and Gene Therapy, Oregon Health and Science University, United States of AmericaSession 4.3: Therapy 3: reproductive options and mtDNA editing
Tea Break and poster session
Milenkovic, DusankaMax Planck Institute for Biology of Ageing, D-50931 Cologne, GermanyTea Break and poster session
Tea Break and poster session  Presenter
Milioni, SaraUniversity of Bologna, Department of Pharmacy and Biotechnology, Italy;
University of Bologna, Department of Medical and Surgical Sciences, Italy
Tea Break and poster session
Milisenda, José CésarLaboratory of Inherited Metabolic Disorders and Muscle Disease, Centre de Recerca Biomèdica CELLEX - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine and Health Sciences - Universitat de Barcelona (UB); Barcelona, Spain.;
Internal Medicine Department - Hospital Clínic de Barcelona; Barcelona, Spain.;
Department of Internal Medicine, Hospital Clinic of Barcelona, Barcelona, Spain;
CIBERER— Spanish Biomedical Research Centre in Rare Diseases, Madrid, Spain
Poster session
Poster session
Milisenda, Jose CesarDepartment of Internal Medicine, Hospital Clínic of Barcelona.Session 2.2: Clinical 1: from new genes to old and novel phenotypes
Milisenda, José CésarHereditary Metabolic Diseases and Muscular Diseases Lab, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain;
Department of Internal Medicine, Hospital Clinic of Barcelona, Barcelona, Spain;
CIBERER— Spanish Biomedical Research Centre in Rare Diseases, Madrid, Spain
Tea Break and poster session
Milisenda, Jose CesarDepartment of Internal Medicine, Hospital Clínic of Barcelona.Tea Break and poster session
Millán, IvánUniversité Paris Cité, NeuroDiderot, Inserm, F-75019 Paris, France;
Neonatal Research Group, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain;
Laboratory of Comparative Neurobiology, Cavanilles Institute of Biodiversity and Evolutionary Biology, University of Valencia, Valencia, Spain
Poster session
Millan, IvanUniversité Paris Cité, NeuroDiderot, Inserm, F-75019 Paris, France;
Neonatal Research Group, Health Research Institute La Fe, 46026 Valencia, Spain;
Laboratory of Comparative Neurobiology, Cavanilles Institute of Biodiversity and Evolutionary Biology, University of Valencia, Valencia, Spain
Tea Break and poster session
Miller, ChayaHadassah Medical Center and Hebrew University of Jerusalem, IsraelTea Break and poster session
Miller, StenNational Institute of Chemical Physics and Biophysics, Estonia;
Tallinn University of Technology, Estonia
Poster session  Presenter
Milne, PaulThe Human Dendritic Cell Lab, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne;
Equal Contributions
Session 1.1: The impact of mtDNA variation and environment on rare and common diseases
Mimitou, EleniTechnology Innovation Lab, New York Genome Center, New York, NY 10013, USA;
Current address: Immunai, New York, NY 10114, USA
Session 2.4: New technological developments and OMICS
Minardi, RIRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, Bologna, ItalyTea Break and poster session
Minardi, RaffaellaIRCCS Istituto delle Scienze Neurologiche, ItalyPoster session  Presenter
Tea Break and poster session
Tea Break and poster session
Minassian, BergeProgram in Genetics and Genome Biology, The Hospital for Sick Children, Institute of Medical Science University of Toronto, Toronto, Ontario, Canada;
Division of Neurology, Department of Pediatrics, University of Texas Southwestern, Dallas, TX, USA
Session 2.3: Modelling pathogenic mechanisms: OXPHOS, metabolic rewiring and tissue specificity
Minczuk, MichalUniversity of Cambridge, United KingdomPoster session
Minczuk, MichalMedical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UKSession 2.4: New technological developments and OMICS
Minczuk, MichalMRC Mitochondrial Biology Unit, Cambridge, United KingdomSession 3.3: Metabolic stress responses in mitochondrial diseases and cancer
Session 4.3: Therapy 3: reproductive options and mtDNA editing
Session 4.3: Therapy 3: reproductive options and mtDNA editing  Presenter
Minczuk, MichalMedical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge UKTea Break and poster session
Mínguez, PabloSpanish Network for Biomedical Research in Rare Diseases (CIBERER);
Instituto de Investigación Sanitaria, Hospital Universitario FundaciónJiménez Díaz, Madrid, Spain
Tea Break and poster session
Misic, JelenaDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, SwedenTea Break and poster session
Mitalipov, ShoukhratOregon Health & Science University, United States of AmericaSession 4.3: Therapy 3: reproductive options and mtDNA editing
Mitalipov, ShoukhratCenter for Embryonic Cell and Gene Therapy, Oregon Health and Science University, United States of AmericaSession 4.3: Therapy 3: reproductive options and mtDNA editing
Tea Break and poster session
Mitchel, CraigKing Abdullah University of Science and Technology (KAUST)Tea Break and poster session
Mito, TakayukiSTEMM, Faculty of Medicine, University of Helsinki, 00290 Helsinki, FinlandPoster session
Mito, TakayukiSTEMM Research Program, Biomedicum Helsinki, Faculty of Medicine, University of Helsinki, Helsinki, FinlandPoster session  Presenter
Mitro, NicoDepartment of Pharmacological and Biomolecular Sciences -DiSFeB, Università degli Studi di Milano, Milan, Italy;
Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.;
Department of Pharmacological and Biomolecular Sciences - DiSFeB, University of Milan, Italy
Tea Break and poster session  Presenter
Tea Break and poster session
Tea Break and poster session
Mittelbrunn, MariaCSIC- Consejo Superior de Investigaciones Cientificas, SpainSession 3.1: Inflammation and Immunity as mitochondrial contributor to pathology  Presenter
Moe, Aye-MyatWellcome Centre for Mitochondrial Research, Newcastle University, United Kingdom;
NIHR Newcastle Biomedical Research Centre, Newcastle University;
NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;
Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK
Tea Break and poster session
Moedas, MarcoDivision of Molecular Metabolism, Karolinska Institutet, Stockholm, Sweden;
Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden
Tea Break and poster session
Moeriboys, HeatherSheffield Institute for Translational Neuroscience (SITraN), The University of Sheffield, Sheffield, UK.Poster session
Mok, BeverlyBroad Institute, Harvard University, and HHMI, United States of AmericaSession 4.1: Therapy 1: preclinical developments
Tea Break and poster session
Mokkachamy Chellapandi, DeepikaINMG-PGNM, FrancePoster session  Presenter
Mokkachamy Chellapandi, DeepikaInstitut NeuroMyoGene, UMR5261, INSERM U1315, Université Claude Bernard Lyon I Faculté de médecine, Lyon, FranceTea Break and poster session
Molina-Berenguer, MiguelResearch Group on Neuromuscular and Mitochondrial Diseases, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona - Barcelona (Spain);
Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III - Madrid (Spain)
Tea Break and poster session  Presenter
Molina-Granada, DavidResearch Group on Neuromuscular and Mitochondrial Disorders, Vall d’Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain;
Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
Poster session
Molinari, MartaTelethon Institute of Genetics and Medicine,Italy;
Institute for Genetic and Biomedical Research, CNR, Italy
Tea Break and poster session
Molinie, ThibautInstitute for Genetics, University of Cologne, Cologne 50931, Germany;
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne 50931, Germany
Poster session  Presenter
Molla-Zaragoza, PauResearch Group on Neuromuscular and Mitochondrial Diseases, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, Spain;
Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
Session 4.1: Therapy 1: preclinical developments
Monassier, LaurentCRBS, UR7296, Strasbourg, FranceTea Break and poster session
Monassier, LaurentPharmacology laboratory UR7296, Strasbourg University - Strasbourg (France)Tea Break and poster session
Mondal, AyusiDepartment of Experimental Oncology, European Institute of Oncology (IEO), IRCCS Milano, Italy;
European School of Molecular Medicine (SEMM)
Tea Break and poster session  Presenter
Monfrini, EdoardoDino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, Milan 20122, Italy;
Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Milan, Italy
Tea Break and poster session
Monsalve, MariaInstituto de Investigaciones Biomedicas “Alberto Sols” (CSIC-UAM), Madrid, SpainPoster session
Monsalve, MariaInstituto de Investigaciones Biomédicas Alberto Sols, SpainTea Break and poster session  Presenter
Montanen, ToniTampere University, FinlandTea Break and poster session
Montano, VincenzoNeurological Institute, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalySession 4.2: Therapy 2: clinical trials
Montano, VincenzoDepartment of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, Pisa, ItalyTea Break and poster session
Montano, VincenzoNeurological Institute, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyTea Break and poster session
Monteith, KatyInstitute of Evolutionary Biology, School of Biological Sciences, University of Edinburgh, UKTea Break and poster session
Montesinos, JorgeColumbia University, USA;
Centro de Investigaciones Biológicas “Margarita Salas”, Madrid, Spain
Poster session
Monteuuis, GeoffrayDepartment of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, FinlandTea Break and poster session
Monti, BarbaraDepartment of Pharmacy and BioTechnology, University of Bologna, ItalyPoster session
Montoro, CarolinaInstitute for Genetics, University of Cologne, Cologne 50931, Germany;
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne 50931, Germany
Poster session
Montoya, JulioUniversidad de Zaragoza, Zaragoza, SpainPoster session
Monzel, Anna SColumbia University Irving Medical Center, United States of AmericaPoster session
Session 3.4: Clinical 2: natural history, biomarkers and outcome measures
Tea Break and poster session
Monzel, Anna S.Division of Behavioral Medicine, Department of Psychiatry, Columbia University Irving Medical Center, New York NY, USASession 3.2: Mitochondrial mechanisms in neurodegeneration and neurodevelopment  Presenter
Monzio-Compagnoni, GiacomoIRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Dino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, Milan, ItalyPoster session
Moore, AllisonHereditary Neuropathy Foundation, New York, NY, USA (https://www.hnf-cure.org/)Tea Break and poster session  Presenter
Moore, Anthony L.University of SussexPoster session
Moore, DavidDivision of Molecular Metabolism, Karolinska Institutet, Stockholm, SwedenTea Break and poster session
Moore, DavidDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden, SwedenTea Break and poster session
Moraes, CarlosUniversity of Miami, United States of AmericaKeynote Lectures: Carlos Moraes - Thomas Becker  Presenter
Moraes, CarlosUniversity of Miami Miller School of MedicineTea Break and poster session
Moraes, CarlosUniversity of Miami, United States of AmericaTea Break and poster session
Tea Break and poster session
Moraes, Carlos TUniversity of Miami Miller School of Medicine, United States of AmericaSession 2.1: mtDNA maintenance and expression
Moraes, Carlos TUniversity of Miami, United States of AmericaTea Break and poster session
Moraes, Carlos TDepartment of Neurology, University of Miami Miller School of Medicine, Miami USATea Break and poster session
Moraes, Carlos T.University of Miami, United States of AmericaSession 4.1: Therapy 1: preclinical developments
Moraes, Carlos T.University of Miami - Miami, FL, United States of AmericaSession 4.3: Therapy 3: reproductive options and mtDNA editing
Moraes, Carlos T.University of Miami, United States of AmericaTea Break and poster session
Moraes, Carlos T.University of Miami - Miami, FL, United States of AmericaTea Break and poster session
Moraes-Filho, Milton NInstituto de Olhos de Colatina, Colatina, Espírito Santo, BrazilPoster session
Session 1.1: The impact of mtDNA variation and environment on rare and common diseases
Morais, Vanessa A.Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, PortugalPoster session
Poster session
Morales, BlaiSecció d'Errors Congènits del Metabolisme-IBC, Servei de Bioquímica i Genètica Molecular, Hospital Clínic de Barcelona, IDIBAPS, CIBERER, Barcelona, SpainTea Break and poster session
Morales Conejo, MontserratMitochondrial and Neuromuscular Diseases Laboratory, Instituto de Investigación Sanitaria Hospital ‘12 de Octubre’ (‘imas12’), Madrid, Spain;
Spanish Network for Biomedical Research in Rare Diseases (CIBERER), U723, Spain;
Servicio de Medicina Interna, Hospital Universitario ‘12 de Octubre’, Madrid, Spain;
Centro Nacional de Referencia para Errores Congénitos del Metabolismo (CSUR) y Centro Europeo de Referencia para Enfermedades Metabólica Hereditarias (MetabERN), Madrid, Spain
Tea Break and poster session
Morales Saute, Jonas A.Medical Genetics Service, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil;
Department of Internal Medicine, Universidade Federal do Rio Grande do Sul - Porto Alegre, Brazil;
Graduate Program in Medicine: Medical Sciences, Universidade Federal do Rio Grande do Sul - Porto Alegre, Brazil
Session 2.1: mtDNA maintenance and expression
Tea Break and poster session
Morales-Conejo, MontserratCIBERER—Spanish Biomedical Research Centre in Rare Diseases; Madrid, Spain.;
Grupo de Enfermedades Mitocondriales, Instituto de Investigación Hospital 12 de Octubre (imas12). Madrid. Spain.
Poster session
Moran, ConorUniversity of Miami, United States of AmericaSession 2.1: mtDNA maintenance and expression
Tea Break and poster session
Morán, MaríaMitochondrial and Neuromuscular Diseases Laboratory, Instituto de Investigación Sanitaria Hospital ‘12 de Octubre’ (‘imas12’), Madrid, Spain;
Spanish Network for Biomedical Research in Rare Diseases (CIBERER), U723, Spain.
Poster session  Presenter
Moran, MaríaMitochondrial Diseases Laboratory, Research Institute, Universitary Hospital 12 de Octubre (Imas12), 28041 Madrid, Spain.;
Centre for Biomedical Network Research on Rare Diseases (CIBERER), Spain.
Poster session
Morán, MaríaMitochondrial and Neuromuscular Diseases Laboratory, Instituto de Investigación Sanitaria Hospital ‘12 de Octubre’ (‘imas12’), Madrid, Spain;
Spanish Network for Biomedical Research in Rare Diseases (CIBERER), U723, Spain
Tea Break and poster session
Morava, EvaDepartment of Clinical Genomics, Mayo Clinic, Rochester, Minnesota, USATea Break and poster session
Morcillo, PatriciaColumbia University, USATea Break and poster session
Morea, VeronicaInstitute of Molecular Biology and Pathology (IBPM), National Research Council (CNR) of ItalySession 4.1: Therapy 1: preclinical developments
Tea Break and poster session
Morelli, Maria CristinaIRCCS Policlinico Sant’Orsola-Malpighi di Bologna, Bologna, ItalyTea Break and poster session
Morén, ConstanzaInherited metabolic diseases and muscular disorders Lab, Cellex - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine and Health Science - University of Barcelona (UB), Department of Internal Medicine - Hospital Clínic of Barcelona (HCB), 08036 Barcelona, Spain, and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U722), 28029 Madrid, Spain.Poster session
Moreno Lozano, Pedro J.Hereditary Metabolic Diseases and Muscular Diseases Lab, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain;
Department of Internal Medicine, Hospital Clinic of Barcelona, Barcelona, Spain;
CIBERER— Spanish Biomedical Research Centre in Rare Diseases, Madrid, Spain
Tea Break and poster session
Moreno Lozano, Pedro JuanLaboratory of Inherited Metabolic Disorders and Muscle Disease, Centre de Recerca Biomèdica CELLEX - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain;
Department of Internal Medicine, Hospital Clinic of Barcelona, Barcelona, Spain;
CIBERER— Spanish Biomedical Research Centre in Rare Diseases, Madrid, Spain
Poster session
Moreno-Loshuertos, RaquelUniversity of Zaragoza, SpainPoster session  Presenter
Moreno-Loshuertos, RaquelDepartment of Biochemistry and Molecualr and Cellular Biology, Universidad de Zaragoza, Spain;
Institute for Biocomputation and Physics of Complex Systems (BIFI), Zaragoza, Spain
Tea Break and poster session
Moreno-Lozano, Pedro J.Laboratory of Inherited Metabolic Disorders and Muscle Disease, Centre de Recerca Biomèdica CELLEX - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine and Health Sciences - Universitat de Barcelona (UB); Barcelona, Spain.;
Internal Medicine Department - Hospital Clínic de Barcelona; Barcelona, Spain.;
CIBERER—Spanish Biomedical Research Centre in Rare Diseases; Madrid, Spain.
Poster session
Moreno-Mateos, Miguel ÁngelCentro Andaluz de Biología del Desarrollo/Universidad Pablo de Olavide-CSIC-JA, Seville, Spain;
CIBERER, Instituto de Salud Carlos III, Madrid, Spain
Poster session
Moresco, MonicaIRCCS Istituto delle Scienze Neurologiche di Bologna, ItalyPoster session  Presenter
Moresco, MonicaIRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, ItalySession 3.1: Inflammation and Immunity as mitochondrial contributor to pathology
Tea Break and poster session
Mörgelin, MatthiasDivision of Infection Medicine, Department of Clinical Sciences, Lund University, Sweden;
Colzyx AB, Lund, Sweden
Session 3.3: Metabolic stress responses in mitochondrial diseases and cancer
Morillas, YacoPhysiology Department, Biomedical Research Center, University of Granada, Granada, SpainPoster session
Moroni, IsabellaFondazione IRCCS Besta, Milan ItalyTea Break and poster session
Morozova, KseniaNovosibirsk State University, Novosibirsk, Russia;
Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia
Session 4.3: Therapy 3: reproductive options and mtDNA editing
Tea Break and poster session
Morra, FrancescaIRCCS Istituto Neurologico C. Besta, ItalyPoster session
Morris, ChrisClinical and Translational Research Institute, Centre for Life, Newcastle University, UK, NE3 1BZSession 3.2: Mitochondrial mechanisms in neurodegeneration and neurodevelopment
Morrow, RyanChildren's Hospital of Philadelphia, USATea Break and poster session  Presenter
Mortiboys, HeatherUniversity of Sheffield, Sheffield Institute for Translational Neuroscience, United KingdomPoster session
Mortiboys, Heather JSheffield Institute for Translational Neuroscience, University of Sheffield, United KingdomTea Break and poster session
Mosbach, ValentineInstitut NeuroMyoGene, PGNM UMR5261, INSERM U1315, Université Claude Bernard Lyon I Faculté de médecine Rockefeller, Lyon 08 FrancePoster session  Presenter
Mosca, FabioIRCCS Cà Granda Ospedale Maggiore Policlinico Milan, ItalyTea Break and poster session
Mosca, LucianaDepartment of Biochemical Sciences "A. Rossi Fanelli, Sapienza University of Rome, ItalySession 4.1: Therapy 1: preclinical developments
Tea Break and poster session
Moscatelli, AndreaIRCCS Istituto Giannina Gaslini, GenoaTea Break and poster session
Mosegaard, SigneLaboratory Genetic Metabolic Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands;
Research Unit for Molecular Medicine, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark;
Laboratory Genetic Metabolic Diseases, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Gastroenterology, Endocrinology, and Metabolism, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands
Session 3.1: Inflammation and Immunity as mitochondrial contributor to pathology  Presenter
Tea Break and poster session  Presenter
Tea Break and poster session  Presenter
Mosharov, Eugene V.Division of Molecular Therapeutics, Department of Psychiatry, Columbia University Irving Medical Center, New York NY, USA;
New York State Psychiatric Institute, New York NY, USA
Session 3.2: Mitochondrial mechanisms in neurodegeneration and neurodevelopment
Moss, Steven J.Isomerase Therapeutics Ltd, Chesterford Research Park, Cambridge, UKTea Break and poster session
Mossman, EmilyUniversity of Sheffield, Sheffield Institute for Translational Neuroscience, United KingdomPoster session
Tea Break and poster session
Moster, Mark L.Departments of Neurology and Ophthalmology, Wills Eye Hospital and Thomas Jefferson University, Philadelphia, PA, USASession 3.4: Clinical 2: natural history, biomarkers and outcome measures
Session 4.2: Therapy 2: clinical trials
Tea Break and poster session
Tea Break and poster session
Tea Break and poster session
Mostert, LouisHuman Metabolomics, North-West University, South AfricaPoster session
Motori, ElisaInstitute for Biochemistry, University of Cologne, Cologne, Germany;
Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany
Poster session  Presenter
Mounier, RémiPhysiopathology and Genetics of Neurons and Muscles Laboratory, Institut NeuroMyoGène, Lyon, FrancePoster session
Mouri, DjmilaUniversité Paris Cité, NeuroDiderot, Inserm, F-75019 Paris, FrancePoster session  Presenter
Tea Break and poster session
Movilla, NievesUniversity of Zaragoza, SpainPoster session
Mráček, TomášInstitute of Physiology of the Czech Academy of Sciences, Czech RepublicPoster session
Mráček, TomášDepartment of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Prague, Czech RepublicPoster session
Mráček, TomášInstitute of Physiology of the Czech Acad. Sci., Prague, Czech RepublicPoster session
Mracek, TomasLaboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Prague, Czech RepublicPoster session  Presenter
Mráček, TomášLaboratory of Bioenergetics, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech RepublicTea Break and poster session
Tea Break and poster session
Mudartha, DeeptiIMol Polish Academy of Sciences, PolandTea Break and poster session
Muelas, NuriaSpanish Network for Biomedical Research in Rare Diseases (CIBERER);
Hospital Universitari I Politècnic La Fe, Neuromuscular and Ataxias Research Group, Instituto de Investigación Sanitaria La Fe, Valencia
Tea Break and poster session
Muellner-Wong, LindenDepartment of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria,Australia;
Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia;
Department of Biochemistry and Pharmacology, University of Melbourne, Melbourne, Australia
Poster session  Presenter
Poster session
Tea Break and poster session
Mukherjee, DibyantiDepartment of Pediatrics, University of California San Francisco, San Francisco, United StatesSession 5.1: Late breaking news session
Tea Break and poster session
Müller, JulianeUniversity of Cambridge, United KingdomSession 3.2: Mitochondrial mechanisms in neurodegeneration and neurodevelopment
Tea Break and poster session
Munell, FrancinaChildren Neuromuscular Diseases Unit, Pediatrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, SpainSession 4.1: Therapy 1: preclinical developments
Munier, FrancisService d'Ophtalmologie, Hôpital Ophtalmique Jules-Gonin, Lausanne, SwitzerlandSession 4.2: Therapy 2: clinical trials
Tea Break and poster session
Munnich, ArnoldINSERM UMR1163, Université Sorbonne Paris Cité, Institut Imagine, 75015 Paris, FranceTea Break and poster session
Muñoz-Pujol, GerardHospital Clinic, IDIBAPS, CIBERER, Barcelona, SpainPoster session
Muñoz-Pujol, GerardSecció d'Errors Congènits del Metabolisme-IBC, Servei de Bioquímica i Genètica Molecular, Hospital Clínic de Barcelona, IDIBAPS, CIBERER, Barcelona, SpainTea Break and poster session  Presenter
Munro, BenjaminDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UKSession 2.2: Clinical 1: from new genes to old and novel phenotypes
Tea Break and poster session  Presenter
Murai, MasakiDOJINDO LABORATORIESTea Break and poster session
Muraresku, ColleenChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania, USAPoster session
Murayama, K.Center for Medical Genetics, Department of Metabolism, Chiba Children's Hospital, 579-1 Heta-cho, Midori-ku, Chiba, 266-000, JapanTea Break and poster session
Murdock, DeborahThe Children's Hospital of Philadelphia, PA USA;
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
Session 4.1: Therapy 1: preclinical developments
Tea Break and poster session
Murphy, JulieWellcome Centre for Mitochondrial Research, Newcastle University, United KingdomTea Break and poster session
Murray, SeanMito Foundation, Sydney, AustraliaTea Break and poster session
Murry, Daryl JDepartment of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, 986145 Nebraska Medical Center, Omaha, NEPoster session
Musacchia, FrancescoIstituto Italiano di Tecnologia – IIT, Genova, ItalyPoster session
Session 1.1: The impact of mtDNA variation and environment on rare and common diseases
Musiani, FrancescoDepartment of Pharmacy and Biotechnology, University of Bologna, ItalyPoster session
Musokhranova, UlianaInstitut de Recerca Sant Joan de Déu, SpainTea Break and poster session  Presenter
Musumeci, O.Unit of Neurology and Neuromuscular Disorders, Department of Clinical and experimental Medicine, University of Messina, ItalyTea Break and poster session
Musumeci, OlimpiaUnit of Neurology and Neuromuscular Disorders, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.Tea Break and poster session
Mutti, Christian D.MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UKSession 4.3: Therapy 3: reproductive options and mtDNA editing
Muus, ChristophBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA;
Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02134, USA
Session 2.4: New technological developments and OMICS